Integration of mechanical, software and electronic systems technologies for vehicle systems了解行业应用
Supply chain collaboration in design, construction, maintenance and retirement of mission-critical assets了解行业应用
Integration of manufacturing process planning with design and engineering for today’s machine complexity了解行业应用
Insurance & Financial
Visibility, compliance and accountability for insurance and financial industriesExplore Industry
Media & Telecommunications
Faster time to market, fewer errors for Software DevelopmentExplore Industry
Small & Medium Business
Realizing Innovation in the pharmaceutical Industry
Engineer innovations faster and with greater confidence
The disruptive nature of digitalization opens new business opportunities and ways to satisfy customer requirements more efficiently. The concept of Digital Twins covers multiple areas across the Ideation, Realization and Utilization phases of the lifecycle of a product.
Join our three-part webinar series where we start with an overview of digital twins throughout the lifecycle for the pharmaceutical industry and then focus our attention to Performance Engineering and the digital twin of production looking at several modeling and simulation approaches to provide solutions to many of the challenges that surround scale-up and troubleshooting, capable of reducing operating costs across manufacturing and quality divisions.
Digital transformation is a dominant trend in the process industries to address profitability and productivity goals. Advanced process modeling and simulation play a central role in both digital design and intelligent digital operations, by capturing deep process knowledge in a way that can be leveraged within Digital Twins to generate value over the lifetime of the process. In this webinar, we will discuss how simulation can be used in process development from multiple aspects.
Wednesday May 27, | 10:00am ET | Register Here
Speaker: Dana Barrasso, PhD – Strategic Business Director Small Molecule Pharma, PSE
In this talk, case studies within the pharmaceutical sector will be presented to demonstrate the use of mechanistic models in the pharmaceutical industry across the lifecycle – from R&D to operations. Recent advances in integrating mechanistic models with online control and monitoring interfaces will be presented. Finally, strategies will be discussed to increase the adoption of these tools in the pharmaceutical sector, leveraging knowledge from R&D to enable online control.